NO
Last reporting period 30 Jun, 2024
Updated 18 Sep, 2024
Last price
—
Market cap $B
64.868
Exchange
OOTC - OTC
4 %
Last period Net income growth rate
9%
Net income growth rate has increased in 5 years
What is Net income growth rate ?
An indicator of the company's profit growth rate relative to the same periods of previous years.
See also Novo Nordisk
Company Analysis
NONOF valuation, rating, competitors, insights and company profile
Eyestock Rating
NONOF financial analysis by Eyestock methodology
Valuation
NONOF valuation using historical relative method
Statements
NONOF Income Statements, Balance Sheet and Cash Flow Statements
Dividends
NONOF dividend yield and annual dividend
An indicator of the company's profit growth rate relative to the same periods of previous years.
Novo Nordisk`s Net income growth rate for the period ended 2024-06-30 is 4 %
